• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过对1255份人类血液样本的转录组分析揭示与衰老相关的可变剪接驱动新抗原出现

Aging-related alternative splicing drive neoantigen emergence revealed by transcriptome analysis of 1,255 human blood samples.

作者信息

Li Shuhan, Lv Haohao, Zhang Renxin, Li Jinjun, Chen Zhiyuan, Yang Naixue, Dai Shaoxing

机构信息

State Key Laboratory of Primate Biomedical Research, Institute of Primate Translational Medicine, Kunming University of Science and Technology, Kunming, Yunnan, China.

Yunnan Key Laboratory of Primate Biomedical Research, Kunming, Yunnan, China.

出版信息

Front Aging. 2025 May 9;6:1575862. doi: 10.3389/fragi.2025.1575862. eCollection 2025.

DOI:10.3389/fragi.2025.1575862
PMID:40417629
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12098113/
Abstract

This study aimed to identify age-related genes and alternative splicing (AS) events by comprehensive transcriptome analysis of 1,255 healthy blood samples from individuals aged 8-87 years. We identified 1,029 up-regulated and 1,186 down-regulated genes in older individuals, including 17 genes overlapped with known aging-associated genes, such as TFAP2A and Klotho. Gene set enrichment analysis revealed significant alterations in immunoregulatory and metabolic pathways during aging. However, many senescence-associated secretory phenotypes (SASP) involved genes did not exhibit changes in gene expression, suggesting that AS events may reveal additional age-related mechanisms. Aging also altered 6,320 AS events in 4,566 genes, impacting immune-related protein domains. The RNA-binding protein RBMS3 emerged as a key regulator of aging-specific AS events. In addition, neoantigen prediction analyses further identified potential neoantigens generated by aging-related AS events, with the HLA-C14:02 allele presenting the most neoantigenic peptides. Notably, 60 neoantigenic peptides were confirmed using proteomic data from elderly individuals, suggesting their potential as novel targets for anti-aging immunotherapy. Our study provides new insights into the role of alternative splicing in aging, highlights promising avenues for anti-aging immunotherapy.

摘要

本研究旨在通过对1255份年龄在8至87岁的健康个体血液样本进行全面的转录组分析,来鉴定与年龄相关的基因和可变剪接(AS)事件。我们在老年个体中鉴定出1029个上调基因和1186个下调基因,其中包括17个与已知衰老相关基因重叠的基因,如TFAP2A和Klotho。基因集富集分析显示,衰老过程中免疫调节和代谢途径发生了显著变化。然而,许多涉及衰老相关分泌表型(SASP)的基因在基因表达上并未表现出变化,这表明可变剪接事件可能揭示了其他与年龄相关的机制。衰老还改变了4566个基因中的6320个可变剪接事件,影响了与免疫相关的蛋白质结构域。RNA结合蛋白RBMS3成为衰老特异性可变剪接事件的关键调节因子。此外,新抗原预测分析进一步鉴定了由衰老相关可变剪接事件产生的潜在新抗原,其中HLA-C14:02等位基因呈现出最多的新抗原肽段。值得注意的是,利用老年个体的蛋白质组学数据证实了60种新抗原肽段,表明它们有望成为抗衰老免疫治疗的新靶点。我们的研究为可变剪接在衰老中的作用提供了新的见解,突出了抗衰老免疫治疗的有前景的途径。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51b9/12098113/8618d94b3a27/fragi-06-1575862-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51b9/12098113/c7f2e281d914/fragi-06-1575862-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51b9/12098113/55386b8e134d/fragi-06-1575862-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51b9/12098113/ed822c0f6c62/fragi-06-1575862-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51b9/12098113/3b386ebb3512/fragi-06-1575862-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51b9/12098113/17c28f18e111/fragi-06-1575862-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51b9/12098113/8618d94b3a27/fragi-06-1575862-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51b9/12098113/c7f2e281d914/fragi-06-1575862-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51b9/12098113/55386b8e134d/fragi-06-1575862-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51b9/12098113/ed822c0f6c62/fragi-06-1575862-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51b9/12098113/3b386ebb3512/fragi-06-1575862-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51b9/12098113/17c28f18e111/fragi-06-1575862-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51b9/12098113/8618d94b3a27/fragi-06-1575862-g006.jpg

相似文献

1
Aging-related alternative splicing drive neoantigen emergence revealed by transcriptome analysis of 1,255 human blood samples.通过对1255份人类血液样本的转录组分析揭示与衰老相关的可变剪接驱动新抗原出现
Front Aging. 2025 May 9;6:1575862. doi: 10.3389/fragi.2025.1575862. eCollection 2025.
2
Identification of neoantigens derived from alternative splicing and RNA modification.源自可变剪接和RNA修饰的新抗原的鉴定。
Genomics Inform. 2019 Sep;17(3):e23. doi: 10.5808/GI.2019.17.3.e23. Epub 2019 Aug 22.
3
RNA-Seq analysis reveals new evidence for inflammation-related changes in aged kidney.RNA测序分析揭示了老年肾脏中炎症相关变化的新证据。
Oncotarget. 2016 May 24;7(21):30037-48. doi: 10.18632/oncotarget.9152.
4
Downregulation of HNRNPA1 induced neoantigen generation via regulating alternative splicing.HNRNPA1的下调通过调节可变剪接诱导新抗原的产生。
Mol Med. 2024 Jun 12;30(1):85. doi: 10.1186/s10020-024-00849-0.
5
Identification of personalized neoantigen-based vaccines and immune subtype characteristic analysis of glioblastoma based on abnormal alternative splicing.基于异常可变剪接的胶质母细胞瘤个性化新抗原疫苗的鉴定及免疫亚型特征分析
Am J Cancer Res. 2022 Aug 15;12(8):3581-3600. eCollection 2022.
6
Comprehensive profiling of cancer neoantigens from aberrant RNA splicing.从异常 RNA 剪接中全面分析癌症新抗原。
J Immunother Cancer. 2024 May 15;12(5):e008988. doi: 10.1136/jitc-2024-008988.
7
Age-Related Alternative Splicing: Driver or Passenger in the Aging Process?年龄相关的可变剪接:衰老过程中的驱动因素还是乘客?
Cells. 2023 Dec 12;12(24):2819. doi: 10.3390/cells12242819.
8
Splicing neoantigen discovery with SNAF reveals shared targets for cancer immunotherapy.拼接新抗原发现与 SNAF 揭示癌症免疫治疗的共同靶点。
Sci Transl Med. 2024 Jan 17;16(730):eade2886. doi: 10.1126/scitranslmed.ade2886.
9
Profiling of hepatocellular carcinoma neoantigens reveals immune microenvironment and clonal evolution related patterns.肝细胞癌新抗原分析揭示了免疫微环境和克隆进化相关模式。
Chin J Cancer Res. 2021 Jun 30;33(3):364-378. doi: 10.21147/j.issn.1000-9604.2021.03.08.
10
: Identification of personalized alternative splicing based neoantigens with RNA-seq.利用 RNA-seq 鉴定基于个性化剪接的新抗原。
Aging (Albany NY). 2020 Jul 22;12(14):14633-14648. doi: 10.18632/aging.103516.

本文引用的文献

1
The ubiquitin-conjugating enzyme UBE2D maintains a youthful proteome and ensures protein quality control during aging by sustaining proteasome activity.泛素结合酶UBE2D维持年轻的蛋白质组,并通过维持蛋白酶体活性确保衰老过程中的蛋白质质量控制。
PLoS Biol. 2025 Jan 29;23(1):e3002998. doi: 10.1371/journal.pbio.3002998. eCollection 2025 Jan.
2
Metformin-induced RBMS3 expression enhances ferroptosis and suppresses ovarian cancer progression.二甲双胍诱导的RBMS3表达增强铁死亡并抑制卵巢癌进展。
Reprod Biol. 2025 Mar;25(1):100968. doi: 10.1016/j.repbio.2024.100968. Epub 2024 Dec 16.
3
Autophagy-dependent splicing control directs translation toward inflammation during senescence.
自噬依赖性剪接控制在衰老过程中引导翻译朝着炎症方向进行。
Dev Cell. 2025 Feb 3;60(3):364-378.e7. doi: 10.1016/j.devcel.2024.10.008. Epub 2024 Nov 6.
4
Metformin decelerates aging clock in male monkeys.二甲双胍可减缓雄性猴子的衰老时钟。
Cell. 2024 Oct 31;187(22):6358-6378.e29. doi: 10.1016/j.cell.2024.08.021. Epub 2024 Sep 12.
5
Nonlinear dynamics of multi-omics profiles during human aging.人类衰老过程中多组学特征的非线性动力学。
Nat Aging. 2024 Nov;4(11):1619-1634. doi: 10.1038/s43587-024-00692-2. Epub 2024 Aug 14.
6
Neoantigens in cancer immunotherapy: focusing on alternative splicing.肿瘤免疫治疗中的新抗原:聚焦于选择性剪接。
Front Immunol. 2024 Jul 11;15:1437774. doi: 10.3389/fimmu.2024.1437774. eCollection 2024.
7
Modulating the RPS27A/PSMD12/NF-κB pathway to control immune response in mouse brain ischemia-reperfusion injury.调控 RPS27A/PSMD12/NF-κB 通路控制脑缺血再灌注损伤小鼠的免疫反应。
Mol Med. 2024 Jul 22;30(1):106. doi: 10.1186/s10020-024-00870-3.
8
Autoimmunity: the neoantigen hypothesis.自身免疫:新抗原假说
Front Immunol. 2024 Jun 27;15:1432985. doi: 10.3389/fimmu.2024.1432985. eCollection 2024.
9
Identification of pancreatic adenocarcinoma immune subtype associated with tumor neoantigen from aberrant alternative splicing.鉴定与异常可变剪接产生的肿瘤新抗原相关的胰腺腺癌免疫亚型
J Gastrointest Oncol. 2024 Jun 30;15(3):1179-1197. doi: 10.21037/jgo-24-340. Epub 2024 Jun 27.
10
mRNA Vaccine for Alzheimer's Disease: Pilot Study.用于阿尔茨海默病的mRNA疫苗:初步研究。
Vaccines (Basel). 2024 Jun 14;12(6):659. doi: 10.3390/vaccines12060659.